| Name | Title | Contact Details |
|---|
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
Based in California, Lumitron Technologies Inc. was established to develop and commercialize unique x‐ray systems that enable revolutionary new capabilities for ultrahigh‐fidelity imaging, ultra‐low dose radiography, hyper‐precision radiotherapy, as well as element-specific and isotope-specific material identification, assay and imaging.
LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust.
United States Surgical Corporation is a Norwalk, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medco Respiratory Instruments is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.